HealthIT Answers October 25, 2020
Industry Expert

By Amy Abernethy, MD, PhD, Principal Deputy Commissioner & Acting Chief Information Officer, and Vid Desai, Chief Technology Officer, FDA

On a daily basis, the U.S. Food and Drug Administration is responsible for making highly complex and consequential regulatory decisions. To meet this responsibility, the FDA must have a modern approach to the use of technology for its regulatory mission, such as the review of medical product applications and food safety, and other critical functions. The agency must also have a workforce that is empowered to be as nimble and as up-to-date as the products we regulate.

The FDA’s Technology Modernization Action Plan (TMAP) is the blueprint for this work. TMAP has three components: modernization of the FDA’s technical infrastructure...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices, Provider, Technology
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy
What principles should guide artificial intelligence innovation in healthcare?
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer

Share This Article